Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

806 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicentric MFI30 study: Standardization of flow cytometry analysis of CD30 expression in non-Hodgkin lymphoma.
Debliquis A, Baseggio L, Bouyer S, Guy J, Garnache-Ottou F, Genevieve F, Mayeur-Rousse C, Letestu R, Chapuis N, Harrivel V, Bennani H, Lachot S, Loosveld M, Nicolino-Brunet C, Pérès M, Roussel M, Veyrat-Masson R, Jacob MC, Drenou B. Debliquis A, et al. Among authors: peres m. Cytometry B Clin Cytom. 2021 Jul;100(4):488-496. doi: 10.1002/cyto.b.21940. Epub 2020 Aug 17. Cytometry B Clin Cytom. 2021. PMID: 32803917 Free article.
Expression of Exhaustion Markers on CD8+ T-Cell Patterns Predict Outcomes in Septic Patients Admitted to the ICU.
Guinault D, Nicolau-Travers ML, Silva S, Cointault O, Daniau B, Del Bello A, Peres M, Rousset D, Rieunier J, Lavayssiere L, Nogier MB, Hourcastagnou E, Mari A, Kamar N, Vergez F, Faguer S. Guinault D, et al. Among authors: peres m. Crit Care Med. 2021 Sep 1;49(9):1513-1523. doi: 10.1097/CCM.0000000000005047. Crit Care Med. 2021. PMID: 33900216
Tocilizumab added to conventional therapy reverses both the cytokine profile and CD8+Granzyme+ T-cells/NK cells expansion in refractory hemophagocytic lymphohistiocytosis.
Faguer S, Vergez F, Peres M, Ferrandiz I, Casemayou A, Belliere J, Cointault O, Lavayssiere L, Nogier MB, Prevot G, Huart A, Recher C, Rostaing L. Faguer S, et al. Among authors: peres m. Hematol Oncol. 2016 Mar;34(1):55-7. doi: 10.1002/hon.2174. Epub 2014 Oct 13. Hematol Oncol. 2016. PMID: 25312407 No abstract available.
S1P: the elixir of life for naive T cells.
Pérès M, Montfort A, Andrieu-Abadie N, Colacios C, Ségui B. Pérès M, et al. Cell Mol Immunol. 2018 Jul;15(7):657-659. doi: 10.1038/cmi.2017.110. Epub 2017 Oct 30. Cell Mol Immunol. 2018. PMID: 29082923 Free PMC article. No abstract available.
Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy.
Weulersse M, Asrir A, Pichler AC, Lemaitre L, Braun M, Carrié N, Joubert MV, Le Moine M, Do Souto L, Gaud G, Das I, Brauns E, Scarlata CM, Morandi E, Sundarrajan A, Cuisinier M, Buisson L, Maheo S, Kassem S, Agesta A, Pérès M, Verhoeyen E, Martinez A, Mazieres J, Dupré L, Gossye T, Pancaldi V, Guillerey C, Ayyoub M, Dejean AS, Saoudi A, Goriely S, Avet-Loiseau H, Bald T, Smyth MJ, Martinet L. Weulersse M, et al. Among authors: peres m. Immunity. 2020 Oct 13;53(4):824-839.e10. doi: 10.1016/j.immuni.2020.09.006. Immunity. 2020. PMID: 33053331 Free article.
806 results